GILT Accelerates Autoimmunity to the Melanoma Antigen Tyrosinase-Related Protein 1 The Journal of Immunology, 2010 2011,08,31 Xu Zhenjie.

Slides:



Advertisements
Similar presentations
The Journal of Immunology, 2013 March 27; 190: , IF=5.52
Advertisements

T cell-mediated immunity Chapter 8
Introduction to Autoimmunity Alon Monsonego, Ph.D. The department of Microbiology and Immunology Tel:
Daiani Alves Patrícia Assis Tiago Medina New intrinsic- and extrinsic factors of CTLA-4 regulation.
Inducing and expanding regulatory T cell populations by foreign antigen Karsten Kretschmer NATURE IMMUNOLOGY 2005; 6:1219.
MHH, Seminarroom h. Antigen + Basophils + CD4 + T cells  T H 2 cells IL-4 Fc  RI MHC II.
Autonomous role of medullary thymic epithelial cells in central CD4 + T cell tolerance Maria Hinterberger1, Martin Aichinger1, Olivia Prazeres da Costa2,
Volume 141, Issue 2, Pages e2 (August 2011)
Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Functional comparison of thymic B cells and dendritic cells in vivo
Volume 33, Issue 3, Pages (September 2010)
Identification of CD3+CD4−CD8− T Cells as Potential Regulatory Cells in an Experimental Murine Model of Graft-Versus-Host Skin Disease (GVHD)  Fumi Miyagawa,
Volume 26, Issue 3, Pages (March 2007)
Volume 15, Issue 1, Pages (July 2001)
Feedback Regulation of Pathogen-Specific T Cell Priming
Inhibition of Th1 Differentiation by IL-6 Is Mediated by SOCS1
Volume 31, Issue 2, Pages (August 2009)
by Éric Aubin, Réal Lemieux, and Renée Bazin
Ret mouse very large tumors (VLTs) display altered ratios of infiltrating memory to naive T cells: Roles in tumor expansion  Mohammad W. Khan, Viktor.
Volume 32, Issue 3, Pages (March 2010)
Volume 141, Issue 2, Pages e2 (August 2011)
Volume 22, Issue 12, Pages (December 2014)
Volume 137, Issue 3, Pages (September 2009)
Volume 18, Issue 5, Pages (May 2003)
Volume 32, Issue 5, Pages (May 2010)
Cellular Mechanisms of Fatal Early-Onset Autoimmunity in Mice with the T Cell-Specific Targeting of Transforming Growth Factor-β Receptor  Julien C. Marie,
Decreased T-cell receptor signaling through CARD11 differentially compromises forkhead box protein 3–positive regulatory versus TH2 effector cells to.
Thomas R Malek, Aixin Yu, Vladimir Vincek, Paul Scibelli, Lin Kong 
Designing and Maintaining the Mature TCR Repertoire
Volume 40, Issue 4, Pages (April 2014)
Volume 33, Issue 3, Pages (September 2010)
A Two-Step Process for Thymic Regulatory T Cell Development
Filiberto Cedeno-Laurent, Matthew J. Opperman, Steven R
Volume 134, Issue 4, Pages (April 2008)
Role of B cells in TH cell responses in a mouse model of asthma
Volume 29, Issue 6, Pages (December 2008)
Volume 27, Issue 3, Pages (September 2007)
Volume 36, Issue 6, Pages (June 2012)
Volume 37, Issue 3, Pages (September 2012)
Volume 15, Issue 5, Pages (November 2001)
Louise J. McHeyzer-Williams, Michael G. McHeyzer-Williams  Immunity 
Volume 17, Issue 2, Pages (February 2009)
Volume 29, Issue 5, Pages (November 2008)
CTLA-4 Regulates Induction of Anergy In Vivo
T Cells with Low Avidity for a Tissue-Restricted Antigen Routinely Evade Central and Peripheral Tolerance and Cause Autoimmunity  Dietmar Zehn, Michael.
Staphylococcal enterotoxin A–activated regulatory T cells promote allergen-specific TH2 response to intratracheal allergen inoculation  Wei-ping Zeng,
Ret mouse very large tumors (VLTs) display altered ratios of infiltrating memory to naive T cells: Roles in tumor expansion  Mohammad W. Khan, Viktor.
Volume 31, Issue 4, Pages (October 2009)
In Vivo Expansion of Regulatory T cells With IL-2/IL-2 mAb Complexes Prevents Anti- factor VIII Immune Responses in Hemophilia A Mice Treated With Factor.
Volume 26, Issue 4, Pages (April 2007)
Volume 34, Issue 3, Pages (March 2011)
Volume 32, Issue 1, Pages (January 2010)
Antigen-Specific Suppression of a Primed Immune Response by Dendritic Cells Mediated by Regulatory T Cells Secreting Interleukin-10  Ela Martin, Brendan.
Volume 7, Issue 2, Pages (August 1997)
Volume 14, Issue 3, Pages (March 2001)
Volume 131, Issue 6, Pages (December 2006)
Volume 7, Issue 3, Pages (September 1997)
Volume 32, Issue 1, Pages (January 2010)
Notch 1 Signaling Regulates Peripheral T Cell Activation
Luk Van Parijs, Alexander Ibraghimov, Abul K. Abbas  Immunity 
Volume 17, Issue 1, Pages (July 2002)
Volume 22, Issue 3, Pages (March 2005)
Reduced tumor growth in CCR5-deficient mice is associated with perturbed killing ability of Treg cells. Reduced tumor growth in CCR5-deficient mice is.
Volume 32, Issue 5, Pages (May 2010)
Epicutaneous Immunization with Autoantigenic Peptides Induces T Suppressor Cells that Prevent Experimental Allergic Encephalomyelitis  Margaret S. Bynoe,
LSECtin, expressed by B16 cells, inhibits the tumor-specific immune responses both in vivo and in vitro. LSECtin, expressed by B16 cells, inhibits the.
Mice with a B cell–specific deletion of Ets1 do not have increased CD4+ T cell activation. Mice with a B cell–specific deletion of Ets1 do not have increased.
A Key Role of Leptin in the Control of Regulatory T Cell Proliferation
Volume 25, Issue 3, Pages (September 2006)
Volume 38, Issue 2, Pages (February 2013)
Presentation transcript:

GILT Accelerates Autoimmunity to the Melanoma Antigen Tyrosinase-Related Protein 1 The Journal of Immunology, ,08,31 Xu Zhenjie

 GILT ( Gamma-IFN inducible lysosomal thiol reductase) is expressed in APCs, where it localizes to MHC class II-loading compartments.  GILT can facilitates the generation of MHC class II-restricted epitopes from disulfide bond containing Ags.  Melanocyte differentiation Ags are melanosomal integral membrane proteins involved in melanin pigment synthesis. These Ags contain a dileucine-based sorting signal that targets them to the endosomal system where they can be processed for MHC class II-restricted presentation.  However, it is not known how GILT would influence the development of immune responses to these Ags in vivo. 1. Background

2. Materials Cell lines 95-10: an I-A b -restricted T cell hybridoma recognizing murine TRP1 PVD: SCC (squamous cell carcinoma) line B16.F10: Mel (Melanoma line) mice C57BL/6 : wild-type mice TRP1tg mice GILT -/- mice TRP1 Bw RAG -/- TRP1tg mice

3. Methods and results  GILT is required for efficient MHC class II-restricted processing of a TRP1 epitope in vitro.  GILT accelerates the onset of vitiligo in TRP1-specific TCR transgenic mice.  Increased percentage of TRP1-specific transgenic T cells in GILT- deficient mice.  Effector memory cells are increased in the presence of GILT and following development of vitiligo. GILT facilitated class II-restricted processing of TRP1, thereby enhancing T cell activation and accelerating vitiligo.

3.1. GILT is required for efficient MHC class II-restricted processing of TRP1 B16 cells freeze-thaw lysates Immunoblotted with anti-TRP1 mAb control Wild-type miceGILT -/- mice splenic B cells Stained by CD45R and I-A b Flow cytometry Coculture with B16 cells lysates and cells Measuring IL-2 production by ELISA

Positive control, TRP1 peptide Negative control, SCC lysates There was a statistically significant difference between the ability of wild-type and GILT-/- B cells to present the TRP1 epitope.

Wild-type miceGILT -/- mice DCs Stained by CD11c and I-A b Flow cytometry Coculture with B16 cells lysates and cells Measuring IL-2 production by ELISA control There was a statistically significant difference between the ability of wild-type and GILT-/- DCs to present the TRP1 epitope.

3. 2. GILT accelerates the onset of vitiligo mediated by TRP1-specific CD4+ T cells To determine whether GILT would impact the development of a TRP1-specific autoimmune response in vivo, To demonstrate that GILT in APCs is necessary for the accelerated onset of vitiligo,

TRP1tg mice GILT+/- (n = 56) GILT-/- (n =76) Wild type (n=127) A

CD4+ TRP1- specific T cells RAG-/- mice GILT-/- RAG-/- mice Transfer into A GILT in APCs increases the severity and accelerates the onset of vitiligo.

3. 3. Increased percentage of TRP1-specific transgenic T cells in GILT- deficient mice Total cell numbers isolated from thymi, spleens, and lymph nodes of the GILT- positive and -negative strains were identical. CD4:CD8 T cell ratio were observed in the thymus, spleen, or lymph node. CD4+ TRP1- specific T cells RAG-/- mice GILT-/- RAG-/- mice Transfer into

Transgenic T cells were identified by Vβ14 and CD4 staining. The percentage of transgenic T cells in GILT-/-TRP1tg mice increased. To exclude the absence of GILT in T cells as the cause of increased T cells, we evaluated the percentage of nontransgenic T cells.

The expansion of T cells was limited to the TRP1-specific CD4+Vb14+ T cells. TCR was expressed in both GILT-/-TRP1tg mice and TRP1tg mice. The influence of T regulatory (Treg) cell was exclude. ?

3.4 Effector memory cells are increased in the presence of GILT and following development of vitiligo. CD62L - CD44 + (effector memory) CD62L + CD44 + (central memory) CD62L + CD44 - (naive) GILT -/- TRP1tg mice and TRP1tg mice CD4 + Vβ14 + T cells GILT facilitated class II-restricted processing of TRP1, thereby enhancing T cell activation and accelerating vitiligo.